Navigation Links
AMERIGROUP Announces Preliminary Third Quarter Results
Date:10/26/2009

VIRGINIA BEACH, Va., Oct. 26 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) announced today that it expects to report earnings for the third quarter of 2009 in the range of $0.42 to $0.44 per diluted share. The new guidance for the third quarter primarily reflects elevated medical costs associated with the onset of a severe flu season due to the H1N1 virus.

Based on claims paid data through the month of September, the Company now estimates medical costs incurred in the quarter will be above its expectations, due largely to a significant spike in flu related activity which is most pronounced in September. As health officials have noted, the H1N1 virus is particularly virulent among children, pregnant women and other high-risk population groups, and this demographic represents approximately 87% of the Company's 1.7 million members.

In contrast to elevated medical costs in the third quarter, the Company's previously established reserves for medical costs as of June 30, 2009 continue to appear adequate.

The Company currently believes that it will not meet its previously announced 2009 annual earnings guidance of $2.55 to $2.75 per diluted share. The Company is withdrawing its guidance for the current year due to the wide range of medical cost outcomes that may occur in the fourth quarter.

"In September, we experienced a spike in flu-related activity among our Medicaid members," said James G. Carlson, AMERIGROUP Chairman and Chief Executive Officer. "The vast majority of our members are within the demographic most at risk for the flu and we appear to be early in the cycle. With this in mind, it is difficult to determine if, and when, the situation will abate, continue at current trends or worsen."

On October 24th, President Barack Obama signed an Emergency Declaration fo
'/>"/>

SOURCE AMERIGROUP Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 30
2. AMERIGROUP Corporation Names Two New Executives
3. AMERIGROUP Corporation to Host Investor Day
4. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
5. AMERIGROUP Reports Q2 Net Income of $49.6 Million or $0.94 per Diluted Share, Including $0.43 per Diluted Share Positive Impact from Tax Adjustment
6. AMERIGROUP Public Policy Institute, Black Leadership Forum, Inc. Convene Summit to Examine Preterm Birth Policy Solutions
7. AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31
8. AMERIGROUP Corporation to Present at the 19th Annual Wachovia Mid-Year Equity Conference on June 24
9. Dr. Emily Abrams Massey of Atlanta Honored as Healthy Hero by the AMERIGROUP Foundation
10. AMERIGROUP Corporation to Present at The Deutsche Bank 34th Annual Healthcare Conference on May 18
11. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 7, 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ,, NEWORLEANS,Nov.23/PRNewswire/--Thanksgiv...#174;.Stronginitstradition,theClassicrepresentsthe...thanagameforthecityofNewOrleansandthoseinattendanc...GCWasche,thisisachanceforsomedowntimebeforetheywor..., Aftertwoyearsofconstruction,PettyOfficerClaud...
(Date:11/23/2009)... , Animal studies suggest that adding flaxseed oi...s in post-menopausal women and women with diabetes...ternational Journal of Food Safety, Nutrition and ...e National Research Center, in Cairo, Egypt, have ...evaluated how flaxseed oil in the diet might delay...
(Date:11/23/2009)... , Since 1996, crop plants genetically modified t...tain insects, yet safe for people, have been plant...e popularity of these Bt crops, named after the ba... ability to kill some major pests, allowing farmer...y reducing insecticide sprays. , However, since ...
(Date:11/23/2009)... Adding drug to chemo regimen may improve patient... Nov. 23 (HealthDay News) -- A new combination dru...advanced biliary-tract cancers, researchers say. ,...tal Cancer Center in Boston found that survival an...mab (Avastin), an angiogenesis inhibitor that has ...
(Date:11/23/2009)... HIV patients who have it take longer to get sick...hDay News) -- Scientists report that a genetic var...ease progression in HIV-infected patients. , ...ears longer to develop AIDS and die of complicatio...ors that vary across individuals that make a perso...
Breaking Medicine News(10 mins):Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2
...s that getting hospitals conscious about quality o...ts dying in that hospital. 26 percent fewer p...ttack when hospitals used quality-improvement // ...steps included a checklist that doctors, nurses an...
...boratories Thursday announced it had entered a co-...enmark-based Rheoscience A/S for the joint develop...the pact, Rheoscience will fund all costs associat... will pay Rheoscience a pre-determined amount towa...
... and team from the Institute of Tropical Medicine ...al AIDS, in which they have said that the HIV viru...iplication rate and is now more sensitive to anti-...ollected during 2002-03. The researchers compared ...
...on form of thalassaemia disease may not require bl...oglobin E ? thalassaemia—the commonest form of sev...managed without transfusion in many patients, sugg...es of donated blood—a scarce resource in many coun...
...ein has helped bald mice to get fur on the body, s... Catherine C. Thompson and colleagues at Johns...nd studied a gene known as Hairless, which encodes...rmal. But once hair is shed, it does not grow back...
...ss is considering whether to temporarily ban the E...man tests to determine whether a pesticide should ... decide whether to place a one year moratorium on ...es approved by the agency for marketing. The...
Other Medicine News:Health News:Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru 2Health News:US Senate Votes against Testing of Pesticide on Humans 2
(Date:11/23/2009)..., IRVINE,Calif.,Nov.23/PRNewswire/--AdvancedSte...ventionsolutionprovider,announcedtodaytheacquisiti...,aprivatelyhelddeveloperofinnovativedisinfectionpr...infections.Termsoftheacquisitionwerenotdisclosed. ...eadecontaminationtechnologythatprovidesdisinfectio...
(Date:11/20/2009)... , BOSTON, Nov. 20 The Uni... upheld an earlier District Court ruling yesterday...ge Wholesale Price (AWP) pharmaceutical litigation... (Logo: http://www.newscom.com/cgi-bin/prnh/20080...ment that awarded consumers who purchased the phar...
(Date:11/20/2009)... , LOUISVILLE, Ky., Nov. 20 /PRNewswire/ -...tigators (NADDI) today announced a new initiative ...rsor Log Exchange (NPLEx) is a multi-state electro...tions on over-the-counter (OTC) medicines containi...le. The technology for NPLEx is based on a system...
Breaking Medicine Technology:ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 1Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 1SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 3SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 4
...esented on Valopicitabine Combined,with an Investi...il 12, 2007 /PRNewswire-FirstCall/ --,Idenix Pharm...phase,IIb studies of the novel combination of valo...a (Pegasys(R)) in both treatment-naive,and treatme...e-1,strain of the hepatitis C virus (HCV). These d...
...osts of eradicating,poliomyelitis from the remaini...m, are much lower than the long term costs of tryi...a recently developed,monovalent vaccine is almost ...litis than an existing trivalent vaccine. These ar...d in an upcoming,issue of The Lancet. , Both Artic...
Other Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: